
Deals desk · August 3, 2026
AstraZeneca shares fall on reports of Bristol Myers Squibb merger talks
LONDON, August 3. AstraZeneca shares fell after reports that the company and Bristol Myers Squibb have held merger discussions over several months. Analysts described the reports as leaving them "perplexed," per the accounts.
Latest from the wire
See all bulletins →Top of the hour
Updated August 2, 2026The Wire — newest first
Every bulletin dated and ordered by recency. Older stories fade down the board as fresher ones break.
The alert, before the trend
Don't refresh the feed. Let the feed find you.
Subscribe and we'll send the bulletin when it publishes — timestamped, and straight to your inbox.
Subscribe by email